CTOs on the Move

Family Pet Veterinary Hospital

www.FamilyPet.com

 
FamilyPet.com provides great value to both pet businesses and pet owners across North America. With a multitude of brands and advertising models, FamilyPet.com has emerged as a leading online marketing tool for the pet industry. FamilyPet.com focuses on providing a resourceful and convenient destination for pet owners looking for high quality pet care services, products and insurance, along with providing educational information regarding the pet industry as a whole.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

MediBuddy

MediBuddy is one of the best (cashless) healthcare providers in India. At MediBuddy you can book Health check packages, online lab tests, online medicines, online doctor consultation, teleconsultation, dental consultation and many more. You can also bo...

PCA Services

PCA Services Inc. is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Trenton Orthopaedic Group, PA

Trenton Orthopaedic Group, PA is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Creative Community Living

Creative Community Living is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Winfield, KS. To find more information about Creative Community Living, please visit www.cclccl.org

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.